GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study
- PMID: 21079180
- DOI: 10.1212/WNL.0b013e3181fd62d2
GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study
Abstract
Background: Biomarker levels in blood after traumatic brain injury (TBI) may offer diagnostic and prognostic tools in addition to clinical indices. This study aims to validate glial fibrillary acidic protein (GFAP) and S100B concentrations in blood as outcome predictors of TBI using cutoff levels of 1.5 μg/L for GFAP and 1.13 μg/L for S100B from a previous study.
Methods: In 79 patients with TBI (Glasgow Coma Scale score [GCS] ≤12), serum, taken at hospital admission, was analyzed for GFAP and S100B. Data collected included injury mechanism, age, gender, mass lesion on CT, GCS, pupillary reactions, Injury Severity Score (ISS), presence of hypoxia, and hypotension. Outcome was assessed, using the Glasgow Outcome Scale Extended (dichotomized in death vs alive and unfavorable vs favorable), 6 months post injury.
Results: In patients who died compared to alive patients, median serum levels were increased: GFAP 33.4-fold and S100B 2.1-fold. In unfavorable compared to favorable outcome, GFAP was increased 19.8-fold and S100B 2.1-fold. Univariate logistic regression analysis revealed that mass lesion, GFAP, absent pupils, age, and ISS, but not GCS, hypotension, or hypoxia, predicted death and unfavorable outcome. Multivariable analysis showed that models containing mass lesion, pupils, GFAP, and S100B were the strongest in predicting death and unfavorable outcome. S100B was the strongest single predictor of unfavorable outcome with 100% discrimination.
Conclusion: This study confirms that GFAP and S100B levels in serum are adjuncts to the assessment of brain damage after TBI and may enhance prognostication when combined with clinical variables.
Comment in
-
Traumatic brain injury: Serum levels of GFAP and S100B predict outcomes in TBI.Nat Rev Neurol. 2011 Feb;7(2):63. doi: 10.1038/nrneurol.2010.207. Nat Rev Neurol. 2011. PMID: 21391320 No abstract available.
Similar articles
-
GFAP and S100B in the acute phase of mild traumatic brain injury.Neurology. 2012 May 1;78(18):1428-33. doi: 10.1212/WNL.0b013e318253d5c7. Epub 2012 Apr 18. Neurology. 2012. PMID: 22517109
-
Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase.J Trauma. 2010 Jul;69(1):104-9. doi: 10.1097/TA.0b013e3181bbd485. J Trauma. 2010. PMID: 20093985
-
Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP.Acta Neurol Scand. 2010 Mar;121(3):178-85. doi: 10.1111/j.1600-0404.2009.01196.x. Epub 2009 Oct 5. Acta Neurol Scand. 2010. PMID: 19804476
-
Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics.Acta Neurochir (Wien). 2010 Jan;152(1):1-17. doi: 10.1007/s00701-009-0463-6. Epub 2009 Aug 4. Acta Neurochir (Wien). 2010. PMID: 19652904 Review.
-
[S100B protein: a novel biomarker for the diagnosis of head injury].Ann Pharm Fr. 2009 May;67(3):187-94. doi: 10.1016/j.pharma.2009.03.002. Epub 2009 May 5. Ann Pharm Fr. 2009. PMID: 19446668 Review. French.
Cited by
-
Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.J Neurotrauma. 2014 Jan 1;31(1):19-25. doi: 10.1089/neu.2013.3040. Epub 2013 Oct 9. J Neurotrauma. 2014. PMID: 23865516 Free PMC article.
-
A Pilot Study of Saliva MicroRNA Signatures in Children with Moderate-to-Severe Traumatic Brain Injury.J Clin Med. 2024 Aug 27;13(17):5065. doi: 10.3390/jcm13175065. J Clin Med. 2024. PMID: 39274278 Free PMC article.
-
A Versatile Pep-CPDs Nanoprobe for Rapid Detection of mTBI Biomarker in Clinical Instances and Safe Fluorescence Imaging In Vivo for Improved Weight-Drop Mouse Model.Front Bioeng Biotechnol. 2022 Mar 7;10:807486. doi: 10.3389/fbioe.2022.807486. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35340839 Free PMC article.
-
Temporal Changes in Serum S100B Levels From Prehospital to Early In-Hospital Sampling in Patients Suffering Traumatic Brain Injury.Front Neurol. 2022 Apr 8;13:800015. doi: 10.3389/fneur.2022.800015. eCollection 2022. Front Neurol. 2022. PMID: 35469266 Free PMC article.
-
Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury.Neurocrit Care. 2015 Feb;22(1):52-64. doi: 10.1007/s12028-014-0028-2. Neurocrit Care. 2015. PMID: 25052159
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous